Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Vaxcyte (PCVX) Interest Expenses (2019 - 2022)

Vaxcyte (PCVX) has 4 years of Interest Expenses data on record, last reported at $2000.0 in Q2 2022.

  • On a quarterly basis, Interest Expenses fell 71.43% to $2000.0 in Q2 2022 year-over-year; TTM through Mar 2023 was $2000.0, a 71.43% decrease, with the full-year FY2022 number at $2000.0, down 71.43% from a year prior.
  • Interest Expenses reached $2000.0 in Q2 2022 per PCVX's latest filing, down from $7000.0 in the prior quarter.
  • Over the last five years, Interest Expenses for PCVX hit a ceiling of $11000.0 in Q2 2019 and a floor of $2000.0 in Q2 2022.
  • A 4-year average of $7166.7 and a median of $7000.0 in 2019 define the central range for Interest Expenses.
  • On a YoY basis, Interest Expenses climbed as much as 71.43% in 2022 and fell as far as 71.43% in 2022.
  • Tracing PCVX's Interest Expenses over 4 years: stood at $7000.0 in 2019, then changed by 0.0% to $7000.0 in 2020, then changed by 0.0% to $7000.0 in 2021, then tumbled by 71.43% to $2000.0 in 2022.
  • Business Quant data shows Interest Expenses for PCVX at $2000.0 in Q2 2022, $7000.0 in Q2 2021, and $7000.0 in Q1 2020.